Patients transferred for primary PCI display reduced mortality when treatment with abciximab was started early compared with abciximab given in the cathlab. Results from the EUROTRANSFER RegistryEuropean Heart J - Dudek, D; Siudak, Z; Janzon, M (2007)
(Suppl): 384 Abstract.